UCD’s Innovation and Technology Transfer Centre launches its annual report
Thursday, 10 June, 2010
In 2009 NovaUCD continued to develop its expertise, comprehensive programmes and facilities to support innovators and entrepreneurs in commercialising the output of their research.
Key achievements during the last year include:
- €300,000 generated from commercialisation of research
- Seven new UCD spin-out companies incorporated
- 85 invention disclosures reported
- 47 patent applications filed across all areas of life sciences, engineering and information communication technology including:
- 25 priority patent applications
- 17 PCT (Patent Co-operation Treaty) applications
- 5 national/regional patent applications
- 15 licence agreements concluded with a range of indigenous and international companies
- 15 new ventures completed the NovaUCD 2009 Campus Company Development Programme
- BiancaMed successfully raised €6M in second round funding
- UCD’s most successful licence to date, a BSE (Bovine Spongiform Encephalopathy) test, has now earned over €2M in royalty income
- The NovaUCD 2009 Innovation Award was presented to Nicola Mitchell, founder Life Scientific and BioScientific Diagnostics
- 24 knowledge-intensive ventures occupying 85% of the incubation space located at NovaUCD at year end.
By 2014, UCD’s offerings at undergraduate and postgraduate level will be transformed to embed aspects of innovation and entrepreneurship through the Innovation Academy. At 3rd and 4th levels UCD will mainstream courses in innovation and entrepreneurship. This will give all postgraduate students access to a range of transferable skills and a knowledge of business, thus providing them with a wider set of career options beyond their core discipline.
